Generation of a new chimeric antigen receptor (CAR) to target CD23 expressed on B-chronic lymphocytic leukemia (B-CLL) cells

被引：0
|
作者：
Attianese, Greta Maria Paola Giordano [1 ]
Hoyos, Vera [2 ]
Savoldo, Barbara [2 ]
Marin, Virna [1 ]
Brandi, Malika [1 ]
Biondi, Andrea [1 ]
Biagi, Ettore [1 ]
Dotti, GianPietro [2 ]
机构：
[1] Univ Milano Bicocca, Dept Pediat, M Tettamanti Res Ctr, Monza, Italy
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [41] The adhesion molecule (AM) profile of B-chronic lymphocytic leukemia (B-CLL). Correlation with disease activity.
    Angelopoulou, MK
    Kapiris, E
    Kourtis, I
    Siakantaris, MP
    Kittas, C
    Pangalis, GA
    BLOOD, 1997, 90 (10) : 4072 - 4072
  • [42] The adhesion molecule profile of mantle cell lymphoma (MCL) VS B-chronic lymphocytic leukemia (B-CLL).
    Angelopoulou, MK
    Kapiris, E
    Kourtis, E
    Siakantaris, MP
    Kittas, C
    Pangalis, GA
    BLOOD, 1997, 90 (10) : 2327 - 2327
  • [43] HETEROGENOUS PROLIFERATIVE RESPONSE OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS TO DIFFERENT ACTIVATION SIGNALS AND IL-2
    VECCHI, A
    LONGO, R
    MESSORA, C
    SACCHI, S
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 542 - 542
  • [44] Derivation of expanded killer cells from patients with B-chronic lymphocytic leukemia (B-CLL): A potential source for cellular immunotherapy.
    Guven, H
    Gilljam, M
    Chambers, BJ
    Ljunggren, HG
    Christensson, B
    Kimby, E
    Dilber, MS
    BLOOD, 2002, 100 (11) : 595A - 595A
  • [45] Expanded subsets of circulating CD38+T cells in B cell chronic lymphocytic leukemia [B-CLL]
    Bjork, RL
    Mcdaniel, PR
    Saven, A
    Bjork, RL
    CYTOMETRY, 2002, : 107 - 107
  • [46] ENUMERATION OF TG LYMPHOCYTES IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) BY A RAPID DOUBLE-ROSETTING TECHNIQUE
    CILLARI, E
    LIO, D
    SALERNO, A
    LAVIA, MF
    DIAGNOSTIC IMMUNOLOGY, 1984, 2 (04): : 224 - 227
  • [47] IMPORTANCE OF CD38 MARKER IN PROGNOSIS OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) IN THE NEW ERA
    Dukovski, D.
    Trajkova, S.
    Panovska, I.
    Cevreska, L.
    HAEMATOLOGICA, 2016, 101 : 722 - 722
  • [48] Expression of CD23 receptors on B chronic lymphocytic leukaemia cells
    Borland, G
    Doig, A
    Kyle, B
    Matheson, J
    Ozanne, BW
    Lucie, N
    Cushley, W
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 75 - 75
  • [49] PROLIFERATIVE RESPONSE OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES STIMULATED WITH IL2 AND SOLUBLE CD23
    BRIZARD, A
    MOREL, F
    LECRON, JC
    DREYFUS, B
    BRIZARD, F
    BARRA, A
    PREUDHOMME, JL
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 311 - 318
  • [50] The chemokine receptor CXCR-4 is consistently expressed and functionally active in B-cell chronic lymphocytic leukemia (B-CLL)
    Möhle, R
    Faileschmid, C
    Bautz, F
    Kanz, L
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 110 - 110
12345